Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
0(0%)
Results Posted
167%(5 trials)
Terminated
3(43%)

Phase Distribution

Ph phase_1
2
29%
Ph phase_3
1
14%
Ph phase_2
3
43%

Phase Distribution

2

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(3)
Terminated(3)
Other(1)

Detailed Status

Completed3
Terminated3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (33.3%)
Phase 23 (50.0%)
Phase 31 (16.7%)

Trials by Status

completed343%
terminated343%
unknown114%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_3

BMN 110 Phase 3B in Australian Patients

NCT01966029
completedphase_2

Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome)

NCT01515956
terminatedphase_2

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

NCT01609062
terminatedphase_2

Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation

NCT01697319
terminatedphase_1

A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)

NCT01242111
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT01966029Phase 3

BMN 110 Phase 3B in Australian Patients

Completed
NCT01515956Phase 2

Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome)

Completed
NCT01609062Phase 2

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

Terminated
NCT01697319Phase 2

Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation

Terminated
NCT01242111Phase 1

A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)

Terminated
NCT00884949Phase 1

A Study to Evaluate the Safety, Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA

Completed
NCT01858103

BMN 110 US Expanded Access Program

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7